{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:5281051",
      "entity_text" : "hypericin",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04335",
      "entity_text" : "cyclo-oxygenase inhibitor",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Recent reports show hypericin phototherapy can be enhanced by multi-fraction treatment, by the addition of synthetic oxygen carriers, or by co-administration of a cyclo-oxygenase inhibitor to block prostaglandin synthesis and prevent new angiogenesis in tumor sites [XREF_BIBR - XREF_BIBR].",
  "reading_complete" : "2020-08-03T16:44:35Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T16:43:22Z",
  "trigger" : "enhanced",
  "evidence" : [ "hypericin phototherapy can be enhanced by multi-fraction treatment, by the addition of synthetic oxygen carriers, or by co-administration of a cyclo-oxygenase inhibitor" ],
  "pmc_id" : "1762016",
  "score" : 0
}